APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

mRNA Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global mRNA Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174014610322 December 2025186 pages

Choose your research edition.

Industry ResearchmRNA Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal mRNA Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global mRNA Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for mRNA Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for mRNA Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for mRNA Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for mRNA Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of mRNA Drug include Janssen, Sri Lankan Microorganisms, Pfizer, Fosun Pharma, AstraZeneca, Zydus Cadila, Moderna, CureVAC and BioNtech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global mRNA Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of mRNA Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents mRNA Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the mRNA Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

mRNA Drug Segment by Company

Janssen

Sri Lankan Microorganisms

Pfizer

Fosun Pharma

AstraZeneca

Zydus Cadila

Moderna

CureVAC

BioNtech

mRNA Drug Segment by Type

Therapeutic Vaccine

Therapeutic Drugs

Preventive Vaccines

mRNA Drug Segment by Application

Hospital

Clinic

mRNA Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the mRNA Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of mRNA Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of mRNA Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of mRNA Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. mRNA Drug Industry Trends Table 2. mRNA Drug Industry Drivers Table 3. mRNA Drug Industry Opportunities and Challenges Table 4. mRNA Drug Industry Restraints Table 5. Global mRNA Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global mRNA Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global mRNA Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global mRNA Drug Sales Market Share by Manufacturers Table 9. Global mRNA Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global mRNA Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global mRNA Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global mRNA Drug Manufacturers, Product Type & Application Table 13. Global mRNA Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global mRNA Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Therapeutic Vaccine Table 17. Major Manufacturers of Therapeutic Drugs Table 18. Major Manufacturers of Preventive Vaccines Table 19. Global mRNA Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global mRNA Drug Sales by Type (2021-2026) & (k units) Table 21. Global mRNA Drug Sales by Type (2027-2032) & (k units) Table 22. Global mRNA Drug Sales Market Share by Type (2021-2026) Table 23. Global mRNA Drug Sales Market Share by Type (2027-2032) Table 24. Global mRNA Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global mRNA Drug Revenue by Type (2021-2026) & (k units) Table 26. Global mRNA Drug Revenue by Type (2027-2032) & (k units) Table 27. Global mRNA Drug Revenue Market Share by Type (2021-2026) Table 28. Global mRNA Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Global mRNA Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global mRNA Drug Sales by Application (2021-2026) & (k units) Table 33. Global mRNA Drug Sales by Application (2027-2032) & (k units) Table 34. Global mRNA Drug Sales Market Share by Application (2021-2026) Table 35. Global mRNA Drug Sales Market Share by Application (2027-2032) Table 36. Global mRNA Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global mRNA Drug Revenue by Application (2021-2026) & (k units) Table 38. Global mRNA Drug Revenue by Application (2027-2032) & (k units) Table 39. Global mRNA Drug Revenue Market Share by Application (2021-2026) Table 40. Global mRNA Drug Revenue Market Share by Application (2027-2032) Table 41. Global mRNA Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global mRNA Drug Sales by Region (2021-2026) & (k units) Table 43. Global mRNA Drug Sales Market Share by Region (2021-2026) Table 44. Global mRNA Drug Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global mRNA Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America mRNA Drug Sales by Country (2021-2026) & (k units) Table 48. North America mRNA Drug Sales by Country (2027-2032) & (k units) Table 49. Europe mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe mRNA Drug Sales by Country (2021-2026) & (k units) Table 51. Europe mRNA Drug Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific mRNA Drug Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific mRNA Drug Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa mRNA Drug Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa mRNA Drug Sales by Country (2027-2032) & (k units) Table 58. Global mRNA Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global mRNA Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global mRNA Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global mRNA Drug Revenue Market Share by Region (2021-2026) Table 62. Global mRNA Drug Revenue Market Share by Region (2027-2032) Table 63. Janssen Company Information Table 64. Janssen Business Overview Table 65. Janssen mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Janssen mRNA Drug Product Portfolio Table 67. Janssen Recent Development Table 68. Sri Lankan Microorganisms Company Information Table 69. Sri Lankan Microorganisms Business Overview Table 70. Sri Lankan Microorganisms mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sri Lankan Microorganisms mRNA Drug Product Portfolio Table 72. Sri Lankan Microorganisms Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer mRNA Drug Product Portfolio Table 77. Pfizer Recent Development Table 78. Fosun Pharma Company Information Table 79. Fosun Pharma Business Overview Table 80. Fosun Pharma mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fosun Pharma mRNA Drug Product Portfolio Table 82. Fosun Pharma Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AstraZeneca mRNA Drug Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Zydus Cadila Company Information Table 89. Zydus Cadila Business Overview Table 90. Zydus Cadila mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Zydus Cadila mRNA Drug Product Portfolio Table 92. Zydus Cadila Recent Development Table 93. Moderna Company Information Table 94. Moderna Business Overview Table 95. Moderna mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Moderna mRNA Drug Product Portfolio Table 97. Moderna Recent Development Table 98. CureVAC Company Information Table 99. CureVAC Business Overview Table 100. CureVAC mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. CureVAC mRNA Drug Product Portfolio Table 102. CureVAC Recent Development Table 103. BioNtech Company Information Table 104. BioNtech Business Overview Table 105. BioNtech mRNA Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. BioNtech mRNA Drug Product Portfolio Table 107. BioNtech Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. mRNA Drug Distributors List Table 111. mRNA Drug Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. mRNA Drug Product Image Figure 2. Global mRNA Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global mRNA Drug Sales (2021-2032) & (k units) Figure 5. Global mRNA Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 mRNA Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Therapeutic Vaccine Image Figure 9. Therapeutic Drugs Image Figure 10. Preventive Vaccines Image Figure 11. Global mRNA Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global mRNA Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global mRNA Drug Sales Market Share by Type (2021-2032) Figure 14. Global mRNA Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global mRNA Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global mRNA Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global mRNA Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global mRNA Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global mRNA Drug Sales Market Share by Application (2021-2032) Figure 22. Global mRNA Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global mRNA Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global mRNA Drug Revenue Market Share by Application (2021-2032) Figure 25. North America mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America mRNA Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe mRNA Drug Sales Market Share by Country (2021-2032) Figure 32. Germany mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. France mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific mRNA Drug Sales Market Share by Country (2021-2032) Figure 39. China mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. India mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa mRNA Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile mRNA Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global mRNA Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global mRNA Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America mRNA Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe mRNA Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific mRNA Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa mRNA Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. mRNA Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. mRNA Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Vaccine
  • Therapeutic Drugs
  • Preventive Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Janssen
  • Sri Lankan Microorganisms
  • Pfizer
  • Fosun Pharma
  • AstraZeneca
  • Zydus Cadila
  • Moderna
  • CureVAC
  • BioNtech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global mRNA Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global mRNA Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global mRNA Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global mRNA Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global mRNA Drug Market Dynamics
  1. 2.1 mRNA Drug Industry Trends
  2. 2.2 mRNA Drug Industry Drivers
  3. 2.3 mRNA Drug Industry Opportunities and Challenges
  4. 2.4 mRNA Drug Industry Restraints
3 mRNA Drug Market by Manufacturers
  1. 3.1 Global mRNA Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global mRNA Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global mRNA Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global mRNA Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global mRNA Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global mRNA Drug Manufacturers, Product Type & Application
  7. 3.7 Global mRNA Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global mRNA Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 mRNA Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 mRNA Drug Tier 1, Tier 2, and Tier 3
4 mRNA Drug Market by Type
  1. 4.1 mRNA Drug Type Introduction
  2. 4.1.1 Therapeutic Vaccine
  3. 4.1.2 Therapeutic Drugs
  4. 4.1.3 Preventive Vaccines
  5. 4.2 Global mRNA Drug Sales by Type
  6. 4.2.1 Global mRNA Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global mRNA Drug Sales by Type (2021-2032)
  8. 4.2.3 Global mRNA Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global mRNA Drug Revenue by Type
  10. 4.3.1 Global mRNA Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global mRNA Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global mRNA Drug Revenue Market Share by Type (2021-2032)
5 mRNA Drug Market by Application
  1. 5.1 mRNA Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global mRNA Drug Sales by Application
  5. 5.2.1 Global mRNA Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global mRNA Drug Sales by Application (2021-2032)
  7. 5.2.3 Global mRNA Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global mRNA Drug Revenue by Application
  9. 5.3.1 Global mRNA Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global mRNA Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global mRNA Drug Revenue Market Share by Application (2021-2032)
6 Global mRNA Drug Sales by Region
  1. 6.1 Global mRNA Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global mRNA Drug Sales by Region (2021-2032)
  3. 6.2.1 Global mRNA Drug Sales by Region (2021-2026)
  4. 6.2.2 Global mRNA Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America mRNA Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe mRNA Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific mRNA Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa mRNA Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa mRNA Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global mRNA Drug Revenue by Region
  1. 7.1 Global mRNA Drug Revenue by Region
  2. 7.1.1 Global mRNA Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global mRNA Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global mRNA Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global mRNA Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America mRNA Drug Revenue (2021-2032)
  8. 7.2.2 North America mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe mRNA Drug Revenue (2021-2032)
  11. 7.3.2 Europe mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific mRNA Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa mRNA Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa mRNA Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen
  2. 8.1.1 Janssen Company Information
  3. 8.1.2 Janssen Business Overview
  4. 8.1.3 Janssen mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen mRNA Drug Product Portfolio
  6. 8.1.5 Janssen Recent Developments
  7. 8.2 Sri Lankan Microorganisms
  8. 8.2.1 Sri Lankan Microorganisms Company Information
  9. 8.2.2 Sri Lankan Microorganisms Business Overview
  10. 8.2.3 Sri Lankan Microorganisms mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
  12. 8.2.5 Sri Lankan Microorganisms Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer mRNA Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Fosun Pharma
  20. 8.4.1 Fosun Pharma Company Information
  21. 8.4.2 Fosun Pharma Business Overview
  22. 8.4.3 Fosun Pharma mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fosun Pharma mRNA Drug Product Portfolio
  24. 8.4.5 Fosun Pharma Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca mRNA Drug Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Zydus Cadila
  32. 8.6.1 Zydus Cadila Company Information
  33. 8.6.2 Zydus Cadila Business Overview
  34. 8.6.3 Zydus Cadila mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Cadila mRNA Drug Product Portfolio
  36. 8.6.5 Zydus Cadila Recent Developments
  37. 8.7 Moderna
  38. 8.7.1 Moderna Company Information
  39. 8.7.2 Moderna Business Overview
  40. 8.7.3 Moderna mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Moderna mRNA Drug Product Portfolio
  42. 8.7.5 Moderna Recent Developments
  43. 8.8 CureVAC
  44. 8.8.1 CureVAC Company Information
  45. 8.8.2 CureVAC Business Overview
  46. 8.8.3 CureVAC mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CureVAC mRNA Drug Product Portfolio
  48. 8.8.5 CureVAC Recent Developments
  49. 8.9 BioNtech
  50. 8.9.1 BioNtech Company Information
  51. 8.9.2 BioNtech Business Overview
  52. 8.9.3 BioNtech mRNA Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioNtech mRNA Drug Product Portfolio
  54. 8.9.5 BioNtech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 mRNA Drug Value Chain Analysis
  2. 9.1.1 mRNA Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 mRNA Drug Production Mode & Process
  6. 9.2 mRNA Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 mRNA Drug Distributors
  9. 9.2.3 mRNA Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst